Literature DB >> 2558010

Crosslinking of cytochrome c and cytochrome b5 with a water-soluble carbodiimide. Reaction conditions, product analysis and critique of the technique.

M R Mauk1, A G Mauk.   

Abstract

A water soluble carbodiimide, 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC), has been used to crosslink horse heart cytochrome c and trypsin-solubilized bovine liver microsomal cytochrome b5. The reaction was conducted under a variety of solution conditions, and the products were purified by a combination of gel filtration and ion-exchange chromatography. Under all conditions of pH, ionic strength, EDC/protein ratio and reaction time that were studied, multiple 1:1 crosslinked complexes were observed with no evidence of a single, dominant species. Acetate, which is often used as a quencher of such reactions, was found to increase the complexity of the reaction products, presumably through EDC-promoted coupling to cytochrome c. Hydroxylamine treatment of the crosslinked complexes, a procedure frequently used to reverse EDC modification of tyrosyl residues, did not reduce the number of crosslinked components observed. The cytochrome b5 heme group was readily extracted from each of the 1:1 crosslinked complexes by standard techniques, so the crosslinking of heme propionate 7 with Lys79 of cytochrome c that might have been anticipated on the basis of molecular graphics modeling [Salemme, F.R. (1976) J. Mol. Biol. 102, 563-568] was not evident from this analysis. Analysis of HPLC tryptic peptide maps produced from crosslinked complexes revealed reduced specificity of trypsin in hydrolysis of EDC-crosslinked protein-protein complexes and unsatisfactory resolution of crosslinked or branched peptides. Nevertheless, it was possible to demonstrate that residues 52-72 of cytochrome b5, a region predicted to be critical to interaction with cytochrome b5 [Salemme, F.R. (1976) J. Mol. Biol. 102, 563-568] was absent from all peptide maps of 1:1 cytochrome c.cytochrome b5 complexes. Based on these results and a review of the literature involving EDC crosslinking of electron transfer proteins, we conclude that the techniques available for specific protein hydrolysis and separation of crosslinked peptides are not adequate to permit routine unambiguous identification of crosslinking sites in carbodiimide-crosslinked complexes.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2558010     DOI: 10.1111/j.1432-1033.1989.tb15231.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  6 in total

1.  Covalent cross-linking of proteins without chemical reagents.

Authors:  Brigitte L Simons; Mary C King; Terry Cyr; Mary Alice Hefford; Harvey Kaplan
Journal:  Protein Sci       Date:  2002-06       Impact factor: 6.725

2.  Evolutionarily divergent electron donor proteins interact with P450MT2 through the same helical domain but different contact points.

Authors:  H K Anandatheerthavarada; G Amuthan; G Biswas; M A Robin; R Murali; M R Waterman; N G Avadhani
Journal:  EMBO J       Date:  2001-05-15       Impact factor: 11.598

Review 3.  Experimental and theoretical analysis of the interaction between cytochrome c and cytochrome b5.

Authors:  A G Mauk; M R Mauk; G R Moore; S H Northrup
Journal:  J Bioenerg Biomembr       Date:  1995-06       Impact factor: 2.945

4.  Probing weakly polar interactions in cytochrome c.

Authors:  D S Auld; G B Young; A J Saunders; D F Doyle; S F Betz; G J Pielak
Journal:  Protein Sci       Date:  1993-12       Impact factor: 6.725

5.  Investigation of the electron-transfer properties of cytochrome c oxidase covalently cross-linked to Fe- or Zn-containing cytochrome c.

Authors:  T A Alleyne; M T Wilson; G Antonini; F Malatesta; B Vallone; P Sarti; M Brunori
Journal:  Biochem J       Date:  1992-11-01       Impact factor: 3.857

6.  Transmutation of a heme protein.

Authors:  P D Barker; J C Ferrer; M Mylrajan; T M Loehr; R Feng; Y Konishi; W D Funk; R T MacGillivray; A G Mauk
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-15       Impact factor: 11.205

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.